Rhythm Pharmaceuticals to Announce Topline Results from Pivotal Phase 3 TRANSCEND Trial Evaluating Setmelanotide in Patients with  Acquired Hypothalamic Obesity

2 days ago 3
Read Entire Article
  1. Homepage
  2. Finance
  3. Rhythm Pharmaceuticals to Announce Topline Results from Pivotal Phase 3 TRANSCEND Trial Evaluating Setmelanotide in Patients with  Acquired Hypothalamic Obesity

Related

BHM stock touches 52-week low at $10.5 amid market challenges

BHM stock touches 52-week low at $10.5 amid market challenge...

35 minutes ago 0
Lantern Pharma stock hits 52-week low at $2.77 amid market challenges

Lantern Pharma stock hits 52-week low at $2.77 amid market c...

35 minutes ago 0
Greenbrier stock hits 52-week low at $41.33 amid market challenges

Greenbrier stock hits 52-week low at $41.33 amid market chal...

35 minutes ago 0

Trending

1. charlie kirk
2. karoline leavitt
3. michael malone
4. william finn
5. north korean troops cross border
6. arcade fire
7. next gen nyc bravo
8. keystone pipeline
9. viktor hovland
10. predator killer of killers

Popular

Australian whose blood saved 2.4 million babies dies

Australian whose blood saved 2.4 million babies dies

1 month ago 103
College football by the odds: Vegas picks and preview of Ohio State vs. Notre Dame

College football by the odds: Vegas picks and preview of Ohi...

2 months ago 92
What to do in Las Vegas this week: January 2-8

What to do in Las Vegas this week: January 2-8

3 months ago 80
TOUS les JOURS Opens in Henderson!

TOUS les JOURS Opens in Henderson!

2 months ago 69
Sole mates: Find the perfect shoes for your fitness journey

Sole mates: Find the perfect shoes for your fitness journey

2 months ago 64
English (US) English (US) ·
About Us · Contact Us · Terms & Conditions ·

© Sincity Press 2025. All rights are reserved